Cat.#: ACPP-1296
| Despition | Fibroblast Growth Factor-19 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1620 | Human SIX6 Protein (AC1620) | 5 µg | inquiry |
| ACPP-1649 | Human EFNA5 Protein (AC1649) | 2 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
| ACPP-1462 | Human CD34 Protein (AC1462) | 5 µg | inquiry |
| ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg | inquiry |
| ACPP-1773 | Human LIN28 Protein (AC1773) | 2 µg | inquiry |
| ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
| ACPP-1786 | Human FGF 1 Protein (AC1786) | 10 µg | inquiry |
| ACPP-1352 | Myocilin Blocking Peptide (AC1352) | 250 µg | inquiry |
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.